Why Nabriva Shares Are Doubling
Nabriva Therapeutics watched its shares more than double to kick off the week after the firm announced results from its late-stage trial in patients with community-acquired bacterial pneumonia.
All Work
Chris Lange
Adobe, FedEx and More Earnings Coming This Week
24/7 Wall St. has put together a preview of Adobe, FedEx and a few other major companies scheduled to report their quarterly results this coming week.
5 Companies That Stand to Win Big This Hurricane Season
It’s currently estimated that the flood damage and destruction to the overall infrastructure of Houston and the surrounding areas from Hurricane Harvey can be measured in the billions. But who stands to gain the…
Nightstar Therapeutics Announces Potential Pricing for IPO
Nightstar Therapeutics intends to price more than 5 million shares in a range that results in an initial public offering valued up to more than $92 million.
What Argus Has to Say About the Equifax Hack
Equifax saw its shares continue to fall early on Friday, over a week after it came to light that the firm had been hacked.
T2 Biosystems Prices Secondary Offering
T2 Biosystems saw its shares drop handily early on Friday after the firm announced that it would be pricing its secondary offering.
Krystal Biotech Gears Up for IPO
Gene therapy company Krystal Biotech expects to price 3 million shares so that the entire offering is valued up to nearly $38 million.
Why Oracle Earnings Are So Great
Oracle Corp. (NYSE: ORCL) released its fiscal first-quarter financial results after the markets closed on Thursday. The software giant said that it had $0.62 in earnings per share (EPS) and $9.2 billion in revenue,…
Thursday’s Biggest Winners and Losers in the S&P 500
Overall Thursday was a mixed day for the U.S. broad markets. Although the S&P 500 and DJIA did hit all-time interday highs, only the Dow closed at a new high. Crude oil was again…
Why Pfizer Is Pushing the Dow to All-Time Highs
Although the markets were mixed on Thursday, major drug manufacturers proved to be one of the more positive segments on the day.
What to Expect From Oracle Earnings
Oracle is scheduled to release its fiscal first-quarter financial results after the markets close on Thursday.
First Data Prices Secondary Offering
First Data shares took a step back on Thursday after the company announced the pricing of its secondary offering.
What You Need to Know About the Tenet Healthcare Sale
Tenet Healthcare watched its shares make a handy gain early on Thursday after The Wall Street Journal announced that it was exploring the possibility of a sale.
Array BioPharma Slides on Secondary Offering
Array BioPharma saw its shares turn negative early on Thursday after the firm announced a secondary offering.
Halozyme Therapeutics Wins Big on Roche License Agreement
Halozyme Therapeutics saw its shares make a handy gain early on Thursday after the firm announced that it licensed its Enhanze drug-delivery technology to Roche for exclusive development of an “undisclosed therapeutic target.”
Wednesday’s Biggest Winners and Losers in the S&P 500
Although the U.S. broad markets ended the day relatively flat, the S&P 500 touched a new all-time high even if just briefly. Also the DJIA and Nasdaq are also within points of their respective…
Can Retail Actually Grow Holiday Jobs This Year?
The strength of retail sales in the fourth quarter of each year is a benchmark for how well the U.S. consumer economy is doing. Over the past ten years, the number of jobs added…
Is This the Start of the Inventure Foods Turnaround?
Shares of Inventure Foods saw one of their better gains in the market on Wednesday, after the firm said that it plans to sell its frozen food business.
Target Plans to Add Over 40% More Jobs This Holiday Season
Target saw its shares make a handy gain on Wednesday after the company announced its plans for hiring seasonal help.
Short Sellers Can’t Make Up Their Minds on Cybersecurity Stocks
The August 31 short interest data have been compared with the previous figures, and short interest moves in these selected cybersecurity stocks were mixed.